A/s Novo, 10% Owner at Tobira Therapeutics, Inc. (TBRA), sold 66,814 shares at $13.77 ($871K) on 2016-06-28, disclosed to the SEC on 2016-06-30.
Open-market sale of $871k TBRA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.77 | 20,883 | $288K | 33.0% |
| 2 | $14.28 | 2,730 | $39K | 4.5% |
| 3 | $12.63 | 16,068 | $203K | 23.3% |
| 4 | $12.58 | 27,133 | $341K | 39.2% |
| Total | $13.04 avg | 66,814 | $871K | 100% |
| Filing → |
| RETA | SELL | 2017-06-07 | $2.5M | — | Filing → |
| APEN | SELL | 2017-05-11 | $582K | — | Filing → |
| OPHT | SELL | 2016-12-16 | $17.6M | — | Filing → |